• About us
• Contact

Advertisement

Organisation › Details

Mirador Therapeutics Inc.

Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360™ precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA. *

 

	Start	2024-03-21 existent
	Industry	drug development
	Industry 2	Mirador360™ precision development engine
	Person	Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic)
	Region	San Diego, CA
	Country	United States (USA)
	Street	3115 Merryfield Row Suite 210
	City	92121 San Diego, CA
		Address record changed: 2024-03-24
Basic data	Employees	n. a.
		* Document for »About Section«: Mirador Therapeutics, Inc.. (3/21/24). "Press Release: Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases". San Diego, CA.
		Record changed: 2024-03-31

Advertisement

More documents for Mirador Therapeutics Inc.

• [1] Mirador Therapeutics, Inc.. (3/21/24). "Press Release: Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases". San Diego, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.